1. WRAIR Report: Phase III Clinical trial of halofantrine in the treatment of falciparum malaria, Chantaburi, Thailand, 1982–1984;Boudreau,1984
2. WRAIR Report on antimalarial drug project experiment number 15: Pharmacokinetics and bioavailability of orally administered halofantrine (WR 171, 699.HC1) in healthy volunteers;Fleckenstein,1983
3. WRAIR Report: Ion-paired liquid chromatographic method for the analysis of halofantrine (WR 171, 669) and its putative metabolite, WR 178,460, in blood and plasma.;Lin,1985
4. Influence of food on the bioavailability of drugs;Melander;Clin. Pharmacokinel,1978
5. WRAIR Report: The comparative bioavailability of three oral formulations of halofantrine hydrochloride in healthy human subjects;Shmuklarsky,1987